10.05.2005 22:31:00
|
Susan Vogt to leave Millipore
Business Editors/Health Editors
BILLERICA, Mass.--(BUSINESS WIRE)--May 10, 2005--Millipore Corporation (NYSE:MIL) announced today that Susan Vogt, president of Millipore's BioPharmaceutical Division, will be leaving Millipore on May 27, 2005 to pursue other interests. Martin Madaus, Millipore's Chairman and CEO, will lead the division until a successor is named.
About Millipore
Millipore is a multinational bioscience company that provides technologies, tools and services for the development and production of new therapeutic drugs. It serves the life science research, biotechnology and pharmaceutical industries. For more information about Millipore visit www.millipore.com.
--30--GK/bo*
CONTACT: Millipore Investor Contact Geoffrey Helliwell, 978-715-1041 or 800-225-3384 Geoffrey_Helliwell@Millipore.com or Media Contact Thomas Anderson, 978-715-1043 or 800-225-3384 Thomas_Anderson@Millipore.com
KEYWORD: MASSACHUSETTS INDUSTRY KEYWORD: MEDICAL PHARMACEUTICAL BIOTECHNOLOGY MANAGEMENT CHANGES SOURCE: Millipore
Copyright Business Wire 2005
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Merck KGaAmehr Nachrichten
Analysen zu Merck KGaAmehr Analysen
09.01.25 | Merck Buy | Goldman Sachs Group Inc. | |
07.01.25 | Merck Market-Perform | Bernstein Research | |
11.12.24 | Merck Overweight | JP Morgan Chase & Co. | |
03.12.24 | Merck Overweight | JP Morgan Chase & Co. | |
02.12.24 | Merck Kaufen | DZ BANK |
Aktien in diesem Artikel
Merck KGaA | 142,30 | 0,42% |
Indizes in diesem Artikel
S&P 500 | 5 827,04 | -1,54% |